Literature DB >> 33040275

Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.

Yujia Wang1, Lushuang Xu1, Yang Liu2, Yuzhe Hu1, Qiang Shi3, Lixue Jin1, Lijun Yang1, Pingzhang Wang1, Kunshan Zhang4, Xiaojun Huang2, Qing Ge5,6,7, Jin Lu8,9.   

Abstract

Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the presence of B cells producing amyloidogenic immunoglobulin light chains (LCs). The low frequency of aberrant B cells in AL is often masked by a polyclonal B cell background, making it difficult for treatment. We analyzed the single-cell RNA sequencing data from GEO database to compare the plasma cell (PCs) in four individuals with AL amyloidosis, one AL subject after treatment, and six healthy controls. High interindividual variability in AL-derived PCs in their expression pattern of known overexpressed genes in multiple myeloma and their usage of V regions in LCs was demonstrated. We also found overexpression of MHC class I molecules as one of the common features of clonal PCs in individuals with AL amyloidosis. Significantly reduced frequencies of circulating natural killer (NK) cells were also observed in a small cohort of AL patients when compared to healthy controls. These data demonstrate that aberrant PCs in AL has a highly diverse transcriptome, an upregulation of MHC, and a dampened capability of immunosurveillance by reduction of circulating NK frequencies. The analysis of clonal PCs at single cell level may provide a better approach for precise molecular profiling and diagnosis of AL amyloidosis.

Entities:  

Keywords:  Immunoglobulin light chain amyloidosis; Natural killer cells; Plasma cells; Single-cell RNA sequencing

Mesh:

Year:  2020        PMID: 33040275     DOI: 10.1007/s12185-020-03016-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  49 in total

Review 1.  Dangerous small B-cell clones.

Authors:  Giampaolo Merlini; Marvin J Stone
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

2.  CyBorD: stellar response rates in AL amyloidosis.

Authors:  Giampaolo Merlini
Journal:  Blood       Date:  2012-05-10       Impact factor: 22.113

3.  Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).

Authors:  Tilmann Bochtler; Ute Hegenbart; Christiane Heiss; Axel Benner; Marion Moos; Anja Seckinger; Stephanie Pschowski-Zuck; Désirée Kirn; Kai Neben; Claus R Bartram; Anthony D Ho; Hartmut Goldschmidt; Dirk Hose; Anna Jauch; Stefan O Schonland
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

4.  Comprehensive Integration of Single-Cell Data.

Authors:  Tim Stuart; Andrew Butler; Paul Hoffman; Christoph Hafemeister; Efthymia Papalexi; William M Mauck; Yuhan Hao; Marlon Stoeckius; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

Review 5.  Systemic immunoglobulin light chain amyloidosis.

Authors:  Giampaolo Merlini; Angela Dispenzieri; Vaishali Sanchorawala; Stefan O Schönland; Giovanni Palladini; Philip N Hawkins; Morie A Gertz
Journal:  Nat Rev Dis Primers       Date:  2018-10-25       Impact factor: 52.329

6.  Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.

Authors:  Bruno Paiva; Joaquin Martinez-Lopez; Luis A Corchete; Beatriz Sanchez-Vega; Inmaculada Rapado; Noemi Puig; Santiago Barrio; Maria-Luz Sanchez; Diego Alignani; Marta Lasa; Alfonso García de Coca; Emilia Pardal; Alberto Oriol; Maria-Esther Gonzalez Garcia; Fernando Escalante; Tomás J González-López; Luis Palomera; José Alonso; Felipe Prosper; Alberto Orfao; Maria-Belen Vidriales; María-Victoria Mateos; Juan-Jose Lahuerta; Norma C Gutierrez; Jesús F San Miguel
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma.

Authors:  Guy Ledergor; Assaf Weiner; Mor Zada; Shuang-Yin Wang; Yael C Cohen; Moshe E Gatt; Nimrod Snir; Hila Magen; Maya Koren-Michowitz; Katrin Herzog-Tzarfati; Hadas Keren-Shaul; Chamutal Bornstein; Ron Rotkopf; Ido Yofe; Eyal David; Venkata Yellapantula; Sigalit Kay; Moshe Salai; Dina Ben Yehuda; Arnon Nagler; Lev Shvidel; Avi Orr-Urtreger; Keren Bahar Halpern; Shalev Itzkovitz; Ola Landgren; Jesus San-Miguel; Bruno Paiva; Jonathan J Keats; Elli Papaemmanuil; Irit Avivi; Gabriel I Barbash; Amos Tanay; Ido Amit
Journal:  Nat Med       Date:  2018-12-06       Impact factor: 53.440

8.  Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.

Authors:  Roshini S Abraham; Karla V Ballman; Angela Dispenzieri; Diane E Grill; Michelle K Manske; Tammy L Price-Troska; Natalia Gonzalez Paz; Morie A Gertz; Rafael Fonseca
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

9.  Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.

Authors:  Joseph R Mikhael; Steven R Schuster; Victor H Jimenez-Zepeda; Nancy Bello; Jacy Spong; Craig B Reeder; A Keith Stewart; P Leif Bergsagel; Rafael Fonseca
Journal:  Blood       Date:  2012-02-13       Impact factor: 22.113

View more
  1 in total

1.  T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy.

Authors:  Yujia Wang; Lushuang Xu; Weijia Zhao; Xiaojie Chen; Lei Wen; Wenbing Duan; Xiao-Juan Yu; Fu- De Zhou; Yang Liu; Jie Hao; Xiaojun Huang; Jin Lu; Qing Ge
Journal:  Clin Transl Med       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.